Steve Cohen: portfolio of Point72 Asset Management
Steve Cohen leads Point72, the successor to SAC Capital; the portfolio holds a very large number of positions and changes often.
Source: 13F filing with the US Securities and Exchange Commission dated Feb 14, 2023. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary Amended on May 15, 2023 – the version known today is shown.
You are looking at Q4 2022. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 26.0B USD
- Positions
- 1,022
- Share of the ten largest
- 14.3%
The ten largest positions Q4 2022
- Meta Platforms 2.2%▲ +140.7%
- Broadcom 1.7%▲ +166.0%
- Salesforce 1.7%new
- Amazon 1.6%▲ +174.8%
- Fidelity National Information Services 1.6%▲ +81.6%
- Biogen 1.3%▼ −26.9%
- Visa Inc. 1.2%▲ +32.7%
- Take-Two Interactive 1.1%▲ +80.1%
- Uber 0.9%▲ +18,546.7%
- Dominion Energy 0.9%▲ +197.1%
Show all positions of this quarter
Choose a quarter (50 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
- Q3 2016
- Q2 2016
- Q1 2016
- Q4 2015
- Q3 2015
- Q2 2015
- Q1 2015
- Q4 2014
- Q3 2014
- Q2 2014
All positions Q4 2022
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| Xenon Pharmaceuticals Inc | 0.2% | 1,178,324 | 46.5M USD | −28.2% reduced | Q1 2015 32 quarters |
| Sanofi | < 0.1% | 500,000 | 24.2M USD | −71.1% reduced | Q1 2018 20 quarters |
| LVS Las Vegas Sands | 0.3% | 1,502,803 | 72.2M USD | −31.7% reduced | Q3 2018 18 quarters |
| Insmed Inc | < 0.1% | 1,291,580 | 25.8M USD | −16.2% reduced | Q3 2018 18 quarters |
| Repligen Corp | < 0.1% | 84,178 | 14.3M USD | −72.6% reduced | Q3 2018 18 quarters |
| Enerplus Corp | 0.1% | 1,650,519 | 29.1M USD | −28.8% reduced | Q4 2018 17 quarters |
| Bread Financial Holdings Inc | < 0.1% | 249,821 | 9.4M USD | 0.0% reduced | Q4 2018 17 quarters |
| Select Sector SPDR TR | < 0.1% | 210,000 | 18.4M USD | −90.0% reduced | Q1 2019 16 quarters |
| Childrens Pl Inc New | < 0.1% | 18,200 | 662.8K USD | −91.3% reduced | Q1 2019 16 quarters |
| JBL Jabil | 0.5% | 1,776,900 | 121.2M USD | −13.9% reduced | Q2 2019 15 quarters |
| Performance Food Group Co | < 0.1% | 228,841 | 13.4M USD | −42.7% reduced | Q2 2019 15 quarters |
| Affimed N V | < 0.1% | 4,207,220 | 5.2M USD | −21.9% reduced | Q3 2019 14 quarters |
| Bicycle Therapeutics PLC | 0.1% | 1,007,978 | 29.8M USD | −19.7% reduced | Q4 2019 13 quarters |
| Neoleukin Therapeutics Inc | < 0.1% | 136,675 | 69.6K USD | −93.4% reduced | Q4 2019 13 quarters |
| MSFT Microsoft | 0.5% | 505,525 | 121.2M USD | −47.2% reduced | Q1 2020 12 quarters |
| AZN AstraZeneca | 0.4% | 1,539,490 | 104.4M USD | −68.0% reduced | Q1 2020 12 quarters |
| Avantor Inc | 0.2% | 2,069,355 | 43.6M USD | −11.8% reduced | Q1 2020 12 quarters |
| Applied Therapeutics Inc | < 0.1% | 719,938 | 547.2K USD | −58.1% reduced | Q1 2020 12 quarters |
| Ishares TR | < 0.1% | 10,000 | 498.2K USD | −50.0% reduced | Q1 2020 12 quarters |
| ADI Analog Devices | 0.9% | 1,355,581 | 222.4M USD | −4.7% reduced | Q2 2020 11 quarters |
| CB Chubb Limited | 0.3% | 387,634 | 85.5M USD | −8.4% reduced | Q2 2020 11 quarters |
| TMUS T-Mobile US | 0.2% | 357,008 | 50.0M USD | −84.4% reduced | Q2 2020 11 quarters |
| Krystal Biotech Inc | 0.2% | 556,252 | 44.1M USD | −55.8% reduced | Q2 2020 11 quarters |
| MRK Merck & Co. | 0.2% | 352,873 | 39.2M USD | −40.7% reduced | Q2 2020 11 quarters |
| Uniqure NV | 0.1% | 1,672,830 | 37.9M USD | −60.7% reduced | Q2 2020 11 quarters |
| GM General Motors | 0.1% | 820,690 | 27.6M USD | −80.1% reduced | Q2 2020 11 quarters |
| Allete Inc | < 0.1% | 287,200 | 18.5M USD | −16.3% reduced | Q2 2020 11 quarters |
| Elastic N V | < 0.1% | 324,965 | 16.7M USD | −26.9% reduced | Q2 2020 11 quarters |
| Bill Com HLDGS Inc | < 0.1% | 114,822 | 12.5M USD | −89.3% reduced | Q2 2020 11 quarters |
| Radnet Inc | < 0.1% | 565,930 | 10.7M USD | −68.8% reduced | Q2 2020 11 quarters |
| Angi Inc | < 0.1% | 1,504,814 | 3.5M USD | −19.8% reduced | Q2 2020 11 quarters |
| BIIB Biogen | 1.3% | 1,226,124 | 339.5M USD | −26.9% reduced | Q3 2020 10 quarters |
| TDY Teledyne Technologies | 0.3% | 176,628 | 70.6M USD | −6.7% reduced | Q3 2020 10 quarters |
| Antero Resources Corp | 0.3% | 2,256,115 | 69.9M USD | −2.9% reduced | Q3 2020 10 quarters |
| MAT Mattel | 0.1% | 2,178,742 | 38.9M USD | −10.9% reduced | Q3 2020 10 quarters |
| Arcutis Biotherapeutics Inc | < 0.1% | 1,103,576 | 16.3M USD | −70.8% reduced | Q3 2020 10 quarters |
| Transalta Corp | < 0.1% | 1,569,275 | 14.0M USD | −13.3% reduced | Q3 2020 10 quarters |
| Inspire Med Sys Inc | 0.4% | 412,924 | 104.0M USD | −15.5% reduced | Q4 2020 9 quarters |
| Chinook Therapeutics Inc | 0.1% | 1,267,660 | 33.2M USD | −48.1% reduced | Q4 2020 9 quarters |
| Pvh Corporation | < 0.1% | 223,813 | 15.8M USD | −42.4% reduced | Q4 2020 9 quarters |
| Tronox Holdings PLC | < 0.1% | 625,349 | 8.6M USD | −10.0% reduced | Q4 2020 9 quarters |
| Alphatec HLDGS Inc | < 0.1% | 379,300 | 4.7M USD | −58.6% reduced | Q4 2020 9 quarters |
| Protagonist Therapeutics Inc | < 0.1% | 316,500 | 3.5M USD | −87.5% reduced | Q4 2020 9 quarters |
| Angiodynamics Inc | < 0.1% | 139,754 | 1.9M USD | −78.7% reduced | Q4 2020 9 quarters |
| ANET Arista Networks | 0.8% | 1,812,261 | 219.9M USD | −8.4% reduced | Q1 2021 8 quarters |
| MLM Martin Marietta Materials | 0.4% | 282,253 | 95.4M USD | −5.4% reduced | Q1 2021 8 quarters |
| Sarepta Therapeutics Inc | 0.4% | 703,755 | 91.2M USD | −17.4% reduced | Q1 2021 8 quarters |
| VMC Vulcan Materials Company | 0.2% | 361,626 | 63.3M USD | −12.6% reduced | Q1 2021 8 quarters |
| VST Vistra Corp. | 0.2% | 2,666,835 | 61.9M USD | −3.9% reduced | Q1 2021 8 quarters |
| Aclaris Therapeutics Inc | 0.1% | 1,782,600 | 28.1M USD | −3.8% reduced | Q1 2021 8 quarters |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Show more (up to 500) Shown: the 50 longest-held of 277 positions.
Plus 400 option positions, value of the underlying shares as reported 2.9B USD – not included in the weights.
The filing states the value of the shares the options refer to. Whether a put is a hedge or a bet on falling prices is not stated in the filing.
- SPDR S&P 500 ETF TR Put 479.8M USD
- SPDR S&P 500 ETF TR Call 266.2M USD
- Humana Put 196.9M USD
- UnitedHealth Group Put 196.8M USD
- Invesco Db Multi-Sector Comm Call 90.7M USD
- Caterpillar Inc. Put 70.4M USD
- Select Sector SPDR TR Put 57.4M USD
- IBM Put 53.6M USD
- Medical Pptys Trust Inc Put 51.2M USD
- AstraZeneca Call 49.9M USD
Plus 52 positions in convertible bonds and bonds worth 472.4M USD as reported – not included in the weights.
Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.
- Novavax Inc principal 29.9M USD 29.8M USD
- Ringcentral Inc principal 27.7M USD 23.9M USD
- Unity Software Inc principal 30.0M USD 22.6M USD
- Splunk Inc principal 21.0M USD 20.3M USD
- Spotify USA Inc principal 24.5M USD 19.8M USD
- Docusign Inc principal 18.5M USD 17.5M USD
- Dish Network Corporation principal 27.0M USD 17.3M USD
- Dish Network Corporation principal 19.0M USD 17.1M USD
- Splunk Inc principal 18.0M USD 17.0M USD
- Sarepta Therapeutics Inc principal 9.0M USD 16.8M USD
Breakdown by sector
- Technology 12.1%
- Financials 7.3%
- Consumer Discretionary 7.0%
- Industrials 6.5%
- Health Care 5.7%
- Communication Services 5.4%
- Utilities 3.5%
- Consumer Staples 2.5%
- Energy 2.3%
- Materials 1.2%
- Real Estate 0.7%
- not in our coverage 45.9%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors